Revision of the EIT Regulation and of the Strategic Innovation Agenda
14 submissions from 14 organizations told the European Commission what they think about this file. Here is what each of them said, in their own words.
Who showed up
6 submissions from industry — companies and their trade associations — against 1 from civil society: NGOs, consumer organizations, environmental groups and trade unions. That is 6 industry submissions for every one from civil society.
Industry 6Civil society 1Public authorities, academia, other 7
Groupings use the respondent type each organization selected when filing. Counting submissions, not organizations — a body that filed twice is counted twice.
The file, right now
The consultation is open — 24 days leftto submit. It closes on 23 Sept 2026.
Responding? PolicySpeak drafts consultation responses grounded in your organization’s own positions. Request access.
Policy area
Education & culture (DG EAC)
Where it stands
In planning
Adoption expected
31 Dec 2026 · in 123 days
How it got here
Call for evidence23 Sept 2026 · upcoming
Also on the Commission’s pipeline for this file, with no date recorded: Initiative planned, Proposal for a regulation.
Making Europe the Preferred Home for Clinical Innovation Europe does not lack scientific talent, high-quality universities or early-stage innovation. Its weakness is the transition from invention to clinical validation, reimbursement and rapid scale-up.
Main issues that should be incorporated: Rigid academiaindustry career pathways; Higher energy costs vs. US/China; Disproportionate bureaucracy for biotech/pharma start-ups; Fragmented capital markets pushing EU companies to the US; Grants distribution (Matthew effect) Rigid career pathways between academia and industry.
Strengthening the EITs role in connecting innovation, skills and regional ecosystems The revision of the EIT Regulation and the Strategic Innovation Agenda for 20282034 provides an important opportunity to build upon the institutional framework established during the 20212027 period while adapting it to new technological, economic and regional challenges.
Europe's challenge is increasingly the failure to connect existing capabilities so innovations reach markets and scale. The EIT revision should strengthen this missing connective layer. Build around assets, not organisations. Europe has exceptional technologies, IP, data, laboratories, compute, infrastructure, regulatory expertise, distribution and talent, but they remain fragmented.
Overall we agree broadly with the issues identified; these are the cogent challenges facing the EITs. We recommend (focused on life sciences but generally applicable): 1. make EITs less inward-looking: by making the EIT eco-system a visible and accessible value chain mandated to support all-comers with promising technologies. If this was already the case, it was not adequately visible 2.
Closing the Adaptation Gap - Strategic alignment for the EIT Revision. The LeadaptX Research Initiative (a private association and research hub in Spain focused on human capital and technological adaptation) strongly welcomes the revision of the EIT Regulation. The EITs shift toward the "Choose Europe" ambition, entrepreneurial education, and early-stage innovation is vital for European competitiveness.
I´m writing this feedback as an ex employee of EIT Manufacturing who lost his job due the bankrupcy of the company. This should not have happened. People which have not been responsible for the situation suffered (employees, Startups, the whole innovation network, EITM was suppose to support). A new regulation should consider this and prevent this case.
- EIT / KIC project funding regulations especially the contractual framework is much too complex. - The current regulations on payback of funding based on a possible future valorisation of project results prevent industry participation as in most of the cases the results are only partial results that cannot be valorised by themselves. The revision of the framwork for EIT / KIC should avoid payback regulations
Subject: Evidence Submission - Project PHOENIX: Zero-Water Autonomous Fire Suppression for EU Climate Resilience Dear EIT Regulation Team, I am Tariq Ali AbdAlhameed Mousa, Aviation Electronics Technical Expert with 24 years of service in the Royal Jordanian Air Force. I submit evidence regarding the future EIT Regulation on climate innovation and disaster response technologies.
I submit this feedback on behalf of ROSI, a French industrial deep-tech company developing high-value recycling solutions for photovoltaic modules. ROSI is a strong believer in European innovation policy and a beneficiary of its success. European support, including through the EIC and EIT ecosystem, helped us move breakthrough recycling technologies from research to industrial reality.
1. Do you agree with the main problems and challenges identified, including the need to strengthen Europe’s competitiveness through more effective innovation ecosystems, stronger knowledgetriangle integration and better translation of knowledge into market impact?
Opening of the attached position paper · the full paper is on the Commission’s record (source link above)
Dear Colleagues, Regarding industry - why not counted the research, innovation smart minds category of non EU people in EU , graduated from EU or , as I am. External experts, counsels searching still the way to highlight the minds ?
Scope of this contribution This response submits methodological evidence on two capabilities that bear directly on the evaluation criteria of relevance, effectiveness and efficiency, coherence with other Union programmes, and European added value in the EIT Regulation and SIA revision. First, federated cross-border interoperability for distributed innovation ecosystems, including KICs and RIS regions.
We believe the EIT plays a key role in our innovation ecosystem, however, some reforms are needed to improve the efficiency of the EIT and it's KICs. We welcome the topical coverage of the KICs which align well with our RIS3 priority areas. 1) The ambition and budget of the Regional Innovation Scheme (RIS) should be increased.
Method. Every quote is verbatim from the organization’s own submission to the European Commission, trimmed to its opening passage and never summarized by a model. Where a submission was filed in another EU language we show the English text the European Commission publishes alongside it, labeled on the quote; the original is one click away at the source. Groupings use the respondent type the organization itself selected when filing. We deliberately do not label anyone “supportive” or “opposed” — you read what they wrote and draw your own conclusion. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.